Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCP-AtorFen Extension Study in Dyslipidemia
NCT00664859Phase 3Completed
- Sponsor
- Veloxis Pharmaceuticals
- Start
- Oct 2007
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of LCP-AtorFen in mixed dyslipidemia, sponsored by Veloxis Pharmaceuticals. Started Oct 2007; status: completed.
02
Drugs
LCP-AtorFen
03
Conditions
mixed dyslipidemia
Beyond the preview
Go deeper on NCT00664859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00664859.